Daflon 500 mg in international guidelines: The reference treatment, whatever the stage of chronic venous insufficiency

Phlebolymphology

Volumn , Issue 38, 2002, Pages 81-84

  Shephard, Daniel ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALVENOR; ARDIUM; ARVENUM; CAPIVEN; DAFLON; DETRALEX; DIOSMIN; ELATEC; VARITON; VENITOL;

CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MECHANISM; HUMAN; LEG ULCER; PRACTICE GUIDELINE; PREVALENCE; REVIEW; STANDARD; ULCER HEALING;

EID: 0036980882     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Coleridge Smith PD. The drug treatment of chronic venous insufficiency and venous ulceration. In: Gloviczki P, Yao JST, eds. Handbook of Venous Disorders. Guidelines of the American Venous Forum. London: Arnold;2001.
2. Jantet G, and the RELIEF Study Group. Chronic venous insuffidency: worldwide results of the RELIEF study. Angiology. 2002;53:245-256.
3. Abramowitz L, Godeberge P, Staumont G, Soudan D. Recommandations pour la pratique clinique sur le traitement de la maladie hémorroïdaire. Gastroenterol Clin Biol. 2001;25:674-702.
4. Agnus GB, Allegra C, Arpaia G, et al. Guidelines for the diagnosis and treatment of chronic venous insufficiency. Italian College of Phlebology. Int Angiol. 2001;20(suppl 2 to issue n° 2):1-73.
5. Cospite M, Cospite V. Treatment of haemorrhoids with Daflon 500 mg. Phlebology. 1992;7(suppl 2):53-56.
6. Belcaro G, Cesarone MR, De Sanctis MT, Incandela L, Laurora G. Laser Doppler and transcutaneous oxymetry: modern investigation to assess drug efficacy in chronic venous insufficiency. Int J Microcirc. 1995:15:45-49.
7. Bouskela E, Donyo K. Effecs of oral administration of purified micronized flavonoid fraction on increased micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia-reperfusion in the hamster cheek pouch. Angiology. 1997;48:391-399.
8. Korthuis RJ, Gute DC. Post-ischaemic leucocyte-endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle; cellular mechanisms and effect of Daflon 500 mg. Int J Microcirc Clin Exp. 1997;17(suppl 1):11-17.
9. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg. Int Angiol. 1988;7:39-43.
10. Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of DAFLON 500 mg in venous leg ulcer healing: a double-blind randomized, controlled versus placebo trial in 107 patients. Angiology. 1997;48:77-85.
11. Glinski W, Chodynicka B, Roszkiewicz J, et al. The beneficial augmentative effect of micronized purified flavonoid fraction (MPFF) on the healing of leg ulcers: a multicenter controlled study. Phlebology. 1999;14:151-157.
12. Roztocil K, Stvrtinova V, Strajceek J, Ucinek. Efficacy of a 6-month treatment with Daflon 500mg in patients with venous leg ulcers associated with chronic venous insufficiency. In press.
13. Shoab SS, Porter J, Scurr JH, Coleridge-Smith PD. Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease; a retrospective study. Eur J Vasc Endovasc Surg. 1999;17:313-318.